p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis

American Journal of Pathology

Volumn 187, Issue 5, 2017, Pages 1016-1034

  Shetty, Shwetha K ^a   Tiwari, Nivedita ^a   Marudamuthu, Amarnath S ^a   Puthusseri, Bijesh ^a   Bhandary, Yashodhar P ^a   Fu, Jian ^b   Levin, Jeffrey ^a   Idell, Steven ^a   Shetty, Sreerama ^a  

^a Baylor UT Houston Center for AIDS Research   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAVEOLIN 1; CIGARETTE SMOKE; MICRORNA 34A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; SILICON DIOXIDE; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN; UROKINASE; MICRORNA; MIRN34 MICRORNA, MOUSE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; LUNG ALVEOLUS EPITHELIUM CELL; LUNG EPITHELIUM; LUNG FIBROSIS; LUNG FUNCTION; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; SEPSIS; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; FEEDBACK SYSTEM; IDIOPATHIC PULMONARY FIBROSIS; PHYSIOLOGY; RESPIRATORY MUCOSA;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; APOPTOSIS; CAVEOLIN 1; CELLS, CULTURED; FEEDBACK; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG INJURY; MICE; MICE, INBRED C57BL; MICRORNAS; RESPIRATORY MUCOSA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85019043473     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.12.020     Document Type: Article

References (64)

1. 1 Lakin, N.D., Jackson, S.P., Regulation of p53 in response to DNA damage. Oncogene 18 (1999), 7644–7655.
2. 2 Sui, X., Han, W., Pan, H., p53-Induced autophagy and senescence. Oncotarget 6 (2015), 11723–11724.
3. 3 Granja, A.G., Nogal, M.L., Hurtado, C., Salas, J., Salas, M.L., Carrascosa, A.L., Revilla, Y., Modulation of p53 cellular function and cell death by African swine fever virus. J Virol 78 (2004), 7165–7174.
4. 4 Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., Jacks, T., p53 Is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 (1993), 847–849.
5. 5 Felton-Edkins, Z.A., Kenneth, N.S., Brown, T.R.P., Daly, N.L., Gomez-Roman, N., Grandori, C., Eisenman, R.N., White, R.J., Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2 (2003), 180–183.
6. 6 Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., Hermeking, H., Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6 (2007), 1586–1593.
7. 7 Xi, Y., Shalgi, R., Fodstad, O., Pilpel, Y., Ju, J., Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12 (2006), 2014–2024.
8. 8 Werner, H., Karnieli, E., Rauscher, F.J., LeRoith, D., Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci 93 (1996), 8318–8323.
9. 9 Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., Khalil, A.M., Zuk, O., Amit, I., Rabani, M., Attardi, L.D., Regev, A., Lander, E.S., Jacks, T., Rinn, J.L., A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 (2010), 409–419.
10. 10 Bhandary, Y.P., Shetty, S.K., Marudamuthu, A.S., Midde, K.K., Ji, H.-L., Shams, H., Subramaniam, R., Fu, J., Idell, S., Shetty, S., Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury. PLoS One, 10, 2015, e0123187.
11. 11 Shetty, S.K., Bhandary, Y.P., Marudamuthu, A.S., Abernathy, D., Velusamy, T., Starcher, B., Shetty, S., Regulation of airway and alveolar epithelial cell apoptosis by p53-induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury. Am J Respir Cell Mol Biol 47 (2012), 474–483.
12. 12 Bhandary, Y.P., Shetty, S.K., Marudamuthu, A.S., Gyetko, M.R., Idell, S., Gharaee-Kermani, M., Shetty, R.S., Starcher, B.C., Shetty, S., Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol 302 (2012), L463–L473.
13. 13 Bhandary, Y.P., Shetty, S.K., Marudamuthu, A.S., Ji, H.-L., Neuenschwander, P.F., Boggaram, V., Morris, G.F., Fu, J., Idell, S., Shetty, S., Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol 183 (2013), 131–143.
14. 14 Bhandary, Y.P., Shetty, S.K., Marudamuthu, A.S., Fu, J., Pinson, B.M., Levin, J., Shetty, S., Role of p53-fibrinolytic system cross-talk in the regulation of quartz-induced lung injury. Toxicol Appl Pharmacol 283 (2015), 92–98.
15. 15 Hickman, A.W., Jaramillo, R.J., Lechner, J.F., Johnson, N.F., α-Particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res 54 (1994), 5797–5800.
16. 16 O'Reilly, M.A., Staversky, R.J., Stripp, B.R., Finkelstein, J.N., Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am J Respir Cell Mol Biol 18 (1998), 43–50.
17. 17 Mantell, L.L., Lee, P.J., Signal transduction pathways in hyperoxia-induced lung cell death. Mol Genet Metab 71 (2000), 359–370.
18. 18 Sermeus, A., Michiels, C., Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis, 2, 2011, e164.
19. 19 Sutherland, L.M., Edwards, Y.S., Murray, A.W., Alveolar type II cell apoptosis. Comp Biochem Physiol A Mol Integr Physiol 129 (2001), 267–285.
20. 20 Marudamuthu, A.S., Bhandary, Y.P., Shetty, S.K., Fu, J., Sathish, V., Prakash, Y., Shetty, S., Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury. Am J Pathol 185 (2015), 55–68.
21. 21 Nakashima, N., Kuwano, K., Maeyama, T., Hagimoto, N., Yoshimi, M., Hamada, N., Yamada, M., Nakanishi, Y., The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. J Clin Pathol 58 (2005), 583–589.
22. 22 Marudamuthu, A.S., Shetty, S.K., Bhandary, Y.P., Karandashova, S., Thompson, M., Sathish, V., Florova, G., Hogan, T.B., Pabelick, C.M., Prakash, Y.S., Tsukasaki, Y., Fu, J., Ikebe, M., Idell, S., Shetty, S., Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs. J Biol Chem 290 (2015), 9428–9441.
23. 23 Morse, D., Rosas, I.O., Tobacco smoke-induced lung fibrosis and emphysema. Annu Rev Physiol 76 (2014), 493–513.
24. 24 Mitchell, P.D., Das, J.P., Murphy, D.J., Keane, M.P., Donnelly, S.C., Dodd, J.D., Butler, M.W., Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers. Respir Care 60 (2015), 259–268.
25. 25 Burnham, E.L., Janssen, W.J., Riches, D.W.H., Moss, M., Downey, G.P., The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J 43 (2014), 276–285.
26. 26 Martin, C., Papazian, L., Payan, M.-J., Saux, P., Gouin, F., Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome: a study in mechanically ventilated patients. Chest 107 (1995), 196–200.
27. 27 Uhal, B.D., Joshi, I., Hughes, W.F., Ramos, C., Pardo, A., Selman, M., Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol Lung Cell Mol Physiol 275 (1998), L1192–L1199.
28. 28 Serrano-Mollar, A., Nacher, M., Gay-Jordi, G., Closa, D., Xaubet, A., Bulbena, O., Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 176 (2007), 1261–1268.
29. 29 Spitalieri, P., Quitadamo, M.C., Orlandi, A., Guerra, L., Giardina, E., Casavola, V., Novelli, G., Saltini, C., Sangiuolo, F., Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells. Eur Respir J 39 (2012), 446–457.
30. 30 Feng, Z., Zhang, C., Wu, R., Hu, W., Tumor suppressor p53 meets microRNAs. J Mol Cell Biol 3 (2011), 44–50.
31. 31 Hermeking, H., p53 Enters the microRNA world. Cancer Cell 12 (2007), 414–418.
32. 32 Felekkis, K., Touvana, E., Stefanou, C., Deltas, C., microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14 (2010), 236–240.
33. 33 Wilczynska, A., Bushell, M., The complexity of miRNA-mediated repression. Cell Death Differ 22 (2015), 22–33.
34. 34 Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., Oren, M., Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26 (2007), 731–743.
35. 35 Fridman, J.S., Lowe, S.W., Control of apoptosis by p53. Oncogene 22 (2003), 9030–9040.
36. 36 Solomon, J.M., Pasupuleti, R., Xu, L., McDonagh, T., Curtis, R., DiStefano, P.S., Huber, L.J., Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 26 (2006), 28–38.
37. 37 Kanegai, C.M., Xi, Y., Donne, M.L., Gotts, J.E., Driver, I.H., Amidzic, G., Lechner, A.J., Jones, K.D., Vaughan, A.E., Chapman, H.A., Rock, J.R., Persistent pathology in influenza-infected mouse lungs. Am J Respir Cell Mol Biol 55 (2016), 613–615.
38. 38 Gao, R., Ma, Z., Hu, Y., Chen, J., Shetty, S., Fu, J., Sirt1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol 308 (2015), L847–L853.
39. 39 Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M.A., Xu, C., Mason, W.S., Moloshok, T., Bort, R., Zaret, K.S., Taylor, J.M., miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1 (2004), 106–113.
40. 40 Shetty, S., Kumar, A., Idell, S., Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 17 (1997), 1075–1083.
41. 41 Tiwari, N., Marudamuthu, A.S., Tsukasaki, Y., Ikebe, M., Fu, J., Shetty, S., p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol 15 (2016), L496–L506.
42. 42 Ashcroft, T., Simpson, J.M., Timbrell, V., Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41 (1988), 467–470.
43. 43 Hübner, R.-H., Gitter, W., El Mokhtari, N.E., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., Bewig, B., Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44 (2008), 507–515.
44. 44 Zhao, B., Chen, H., Lei, N., Li, G., Zhao, W., Zhan, Y., Liu, B., Lin, S., Wu, Q., p53 Mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J 25 (2006), 5703–5715.
45. 45 Barlev, N.A., Liu, L., Chehab, N.H., Mansfield, K., Harris, K.G., Halazonetis, T.D., Berger, S.L., Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8 (2001), 1243–1254.
46. 46 Hasegawa, M., Zhang, Y., Niibe, H., Terry, N.H., Meistrich, M.L., Resistance of differentiating spermatogonia to radiation-induced apoptosis and loss in p53-deficient mice. Radiat Res 149 (1998), 263–270.
47. 47 Kunz, C., Pebler, S., Otte, J., von der Ahe, D., Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23 (1995), 3710–3717.
48. 48 Shetty, S., Shetty, P., Idell, S., Velusamy, T., Bhandary, Y.P., Shetty, R.S., Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem 283 (2008), 19570–19580.
49. 49 Coultas, D.B., Zumwalt, R.E., Black, W.C., Sobonya, R.E., The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150 (1994), 967–972.
50. 50 Datta, A., Scotton, C.J., Chambers, R.C., Novel therapeutic approaches for pulmonary fibrosis. Br J Pharmacol 163 (2011), 141–172.
51. 51 Valentin-Vega, Y.A., Okano, H., Lozano, G., The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival. Cell Death Differ 15 (2008), 1772–1781.
52. 52 El-Dahr, S.S., Hilliard, S., Aboudehen, K., Saifudeen, Z., The MDM2–p53 pathway: multiple roles in kidney development. Pediatr Nephrol 29 (2014), 621–627.
53. 53 Lozano, G., Mouse models of p53 functions. Cold Spring Harb Perspect Biol, 2, 2010, a001115.
54. 54 Freedman, D.A., Levine, A.J., Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol 18 (1998), 7288–7293.
55. 55 Tang, Y., Zhao, W., Chen, Y., Zhao, Y., Gu, W., Acetylation is indispensable for p53 activation. Cell 133 (2008), 612–626.
56. 56 Ito, A., Lai, C.H., Zhao, X., Saito, S., Hamilton, M.H., Appella, E., Yao, T.P., p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20 (2001), 1331–1340.
57. 57 Yang, H., Yan, B., Liao, D., Huang, S., Qiu, Y., Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress. Cell Death Dis, 6, 2015, e1747.
58. 58 Zhao, G., Cui, J., Zhang, J.-G., Qin, Q., Chen, Q., Yin, T., Deng, S.-C., Liu, Y., Liu, L., Wang, B., Tian, K., Wang, G.-B., Wang, C.-Y., SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther 18 (2011), 920–928.
59. 59 Lee, J.T., Gu, W., SIRT1: regulator of p53 deacetylation. Genes Cancer 4 (2013), 112–117.
60. 60 Yamakuchi, M., Ferlito, M., Lowenstein, C.J., miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105 (2008), 13421–13426.
61. 61 Shetty, P., Velusamy, T., Bhandary, Y.P., Shetty, R.S., Liu, M.-C., Shetty, S., Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover. Am J Respir Cell Mol Biol 39 (2008), 364–372.
62. 62 Shetty, S., Velusamy, T., Idell, S., Shetty, P., Mazar, A.P., Bhandary, Y.P., Shetty, R.S., Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA. Mol Cell Biol 27 (2007), 5607–5618.
63. 63 Swaisgood, C.M., French, E.L., Noga, C., Simon, R.H., Ploplis, V.A., The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157 (2000), 177–187.
64. 64 Sisson, T.H., Hanson, K.E., Subbotina, N., Patwardhan, A., Hattori, N., Simon, R.H., Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 283 (2002), L1023–L1032.